Genix Pharmaceuticals Corporation

GENPF · OTC
Analyze with AI
7/31/2025
4/30/2025
1/31/2025
10/31/2024
Assets
Cash & Equivalents$3$4$3$11
Short-Term Investments$0$0$0$0
Receivables$1$3$7$6
Inventory$0$0$0$0
Other Curr. Assets$17$28$40$22
Total Curr. Assets$21$35$50$39
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$4$6$6$7
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$2$0$0$0
Total NC Assets$6$6$6$7
Other Assets$0$0$0$0
Total Assets$27$42$56$46
Liabilities
Payables$173$167$172$150
Short-Term Debt$525$965$908$816
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$351$252$266$264
Total Curr. Liab.$1,049$1,384$1,347$1,229
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$1,049$1,384$1,347$1,229
Equity
Pref Stock$0$0$0$0
Common Stock$9,701$9,701$9,701$9,701
Retained Earnings-$12,447-$12,363-$12,311-$12,204
AOCI$1,320$0$0$0
Other Equity$0$1,320$1,320$1,320
Total Equity-$1,426-$1,342-$1,290-$1,183
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$27$42$56$46
Net Debt$522$961$905$804